Dali Pharmaceutical Co. Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 160.894 million compared to CNY 202.985 million a year ago. Operating income was CNY 12.275 million compared to CNY 925,820.21 a year ago. Net income was CNY 12.233 million compared to CNY 885,827.76 a year ago. Basic earnings per share from continuing operations was CNY 0.07 compared to CNY 0.01 a year ago.